AU2004294810C1 - In ovo vaccination of Campylobacter in avian species - Google Patents

In ovo vaccination of Campylobacter in avian species Download PDF

Info

Publication number
AU2004294810C1
AU2004294810C1 AU2004294810A AU2004294810A AU2004294810C1 AU 2004294810 C1 AU2004294810 C1 AU 2004294810C1 AU 2004294810 A AU2004294810 A AU 2004294810A AU 2004294810 A AU2004294810 A AU 2004294810A AU 2004294810 C1 AU2004294810 C1 AU 2004294810C1
Authority
AU
Australia
Prior art keywords
campylobacter
live cells
bird
ovo
polynucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004294810A
Other languages
English (en)
Other versions
AU2004294810A1 (en
AU2004294810B2 (en
Inventor
Tonia Sue Agin
Everett Lee Rosey
Frederick Henry Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Services LLC
Original Assignee
Zoetis Services LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services LLC filed Critical Zoetis Services LLC
Publication of AU2004294810A1 publication Critical patent/AU2004294810A1/en
Application granted granted Critical
Publication of AU2004294810B2 publication Critical patent/AU2004294810B2/en
Publication of AU2004294810C1 publication Critical patent/AU2004294810C1/en
Assigned to ZOETIS P LLC reassignment ZOETIS P LLC Amend patent request/document other than specification (104) Assignors: PFIZER PRODUCTS INC.
Assigned to ZOETIS SERVICES LLC reassignment ZOETIS SERVICES LLC Request to Amend Deed and Register Assignors: ZOETIS P LLC
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2004294810A 2003-12-03 2004-11-22 In ovo vaccination of Campylobacter in avian species Ceased AU2004294810C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52668103P 2003-12-03 2003-12-03
US60/526,681 2003-12-03
PCT/IB2004/003806 WO2005053737A1 (en) 2003-12-03 2004-11-22 In ovo vaccination of campylobacter in avian species

Publications (3)

Publication Number Publication Date
AU2004294810A1 AU2004294810A1 (en) 2005-06-16
AU2004294810B2 AU2004294810B2 (en) 2010-12-16
AU2004294810C1 true AU2004294810C1 (en) 2013-02-14

Family

ID=34652463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004294810A Ceased AU2004294810C1 (en) 2003-12-03 2004-11-22 In ovo vaccination of Campylobacter in avian species

Country Status (7)

Country Link
US (2) US8092808B2 (enExample)
EP (1) EP1691831B1 (enExample)
JP (1) JP4602347B2 (enExample)
AU (1) AU2004294810C1 (enExample)
CA (1) CA2547775C (enExample)
ES (1) ES2422885T3 (enExample)
WO (1) WO2005053737A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101149687B1 (ko) 2006-03-30 2012-05-25 엠브렉스, 인코포레이티드 가금류의 예방접종 방법 및 조성물
TWI423814B (zh) * 2006-09-01 2014-01-21 Genticel 用於引發特異性細胞毒性ｔ淋巴細胞（ｃｔｌ）反應之組成物，包含一淋巴去除性化合物以及一含有抗原序列且以專業化抗原呈現細胞為標靶之分子
WO2009012589A1 (en) * 2007-07-23 2009-01-29 University Of Saskatchewan Vaccines and methods for treatment or prevention of gram negative bacterial infection in a vertebrate subject
MX380859B (es) * 2014-05-09 2025-03-12 Univ Utrecht Holding Bv Nuevos derivados de cath2.
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
EP4132478A1 (en) 2020-04-09 2023-02-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040388A (en) * 1976-02-27 1977-08-09 Agrimatic Corporation Method and apparatus for automatic egg injection
US4593646A (en) * 1982-06-01 1986-06-10 Agrimatic Corporation Egg injection method and apparatus
US4469047A (en) * 1983-10-25 1984-09-04 Miller Gary E Apparatus and method for injecting eggs
US4681063A (en) * 1986-07-02 1987-07-21 Embrex Inc. High speed automated injection system for avian embryos
JPH07206705A (ja) * 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB2298432B (en) * 1995-03-03 1999-04-14 Orion Yhtymae Oy In ovo administration of a competitive exclusion culture
IL128014A (en) * 1996-09-30 2003-11-23 Univ Arkansas Method of producing active immunity with vaccine conjugate, a vaccine preparation useful for the production of said vaccine conjugate and a process for the manufacture of said vaccine
EP0996451B1 (en) * 1997-05-20 2005-01-05 Galenica Pharmaceuticals, Inc. Triterpene saponin analogs having adjuvant and immunostimulatory activity
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US6019985A (en) 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
ATE307606T1 (de) 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NOOR S et al; British Poultry Science (1995), Vol 36, no 4, pgs 563-573 *
ZIPRIN R et al; Poultry Science (!999), Vol 78, No Suppl 1, pg 39 *

Also Published As

Publication number Publication date
EP1691831B1 (en) 2013-05-15
EP1691831A1 (en) 2006-08-23
US20120107351A1 (en) 2012-05-03
US20070116722A1 (en) 2007-05-24
CA2547775C (en) 2012-01-03
US8431138B2 (en) 2013-04-30
ES2422885T3 (es) 2013-09-16
AU2004294810A1 (en) 2005-06-16
AU2004294810B2 (en) 2010-12-16
CA2547775A1 (en) 2005-06-16
US8092808B2 (en) 2012-01-10
JP4602347B2 (ja) 2010-12-22
WO2005053737A1 (en) 2005-06-16
JP2007513138A (ja) 2007-05-24

Similar Documents

Publication Publication Date Title
JP5014413B2 (ja) 家禽のワクチン接種のための方法及び組成物
JP5229637B2 (ja) サルモネラワクチン
US10772954B2 (en) Dual adjuvant vaccine compositions, preparation and uses
US8431138B2 (en) In ovo vaccination of Campylobacter in avian species
JP2004536106A (ja) マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法
EA036764B1 (ru) Ослабленный штамм streptococcus suis, индуцирующий иммунный ответ у свиней, и его применение
JP5745731B2 (ja) サルモネラワクチン
US6632439B2 (en) Fusobacterium necrophorum vaccine and method for making such vaccine
US20180015157A1 (en) Attenuated Pasteurella Multocida Vaccines & Methods of Making & Use Thereof
US9764017B2 (en) Potomac horse fever isolates
JP4705573B2 (ja) 弱毒細菌生ワクチン
CN117794564A (zh) 用于保护以对抗多种血清型的猪链球菌的疫苗
CHICKEN Dr. Suraksha Subedi Deka

Legal Events

Date Code Title Description
CB Opposition filed

Opponent name: MERIAL LTD

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 27 JUL 2012 .

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 27 JUL 2012

CH Opposition withdrawn

Opponent name: MERIAL LTD

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired